Publication | Closed Access

S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine

Epithelial-mesenchymal TransitionTumor BiologyPancreatic CancerMedicineHuman Pdac CellsTumor SuppressorPancreatic Cancer TreatmentRadiation OncologyCancer BiologyCell BiologyCancer Research